Originally published In Press as doi:10.1074/jbc.M909285199 on April 27, 2000
J. Biol. Chem., Vol. 275, Issue 26, 20168-20178, June 30, 2000
Regulation of Peroxisome Size and Number by Fatty Acid
-Oxidation in the Yeast Yarrowia lipolytica*
Jennifer J.
Smith
,
Trevor W.
Brown,
Gary A.
Eitzen§, and
Richard A.
Rachubinski¶
From the Department of Cell Biology, University of Alberta,
Edmonton, Alberta T6G 2H7, Canada
Received for publication, November 19, 1999, and in revised form, April 25, 2000
 |
ABSTRACT |
The Yarrowia lipolytica MFE2 gene
encodes peroxisomal
-oxidation multifunctional enzyme type 2 (MFE2).
MFE2 is peroxisomal in a wild-type strain but is cytosolic in a strain
lacking the peroxisomal targeting signal-1 (PTS1) receptor. MFE2 has a
PTS1, Ala-Lys-Leu, that is essential for targeting to peroxisomes. MFE2 lacking a PTS1 can apparently oligomerize with full-length MFE2 to
enable targetting to peroxisomes. Peroxisomes of an oleic acid-induced MFE2 deletion strain, mfe2-KO, are larger and
more abundant than those of the wild-type strain. Under growth
conditions not requiring peroxisomes, peroxisomes of
mfe2-KO are larger but less abundant than those of the
wild-type strain, suggesting a role for MFE2 in the regulation of
peroxisome size and number. A nonfunctional version of MFE2 did not
restore normal peroxisome morphology to mfe2-KO cells,
indicating that their phenotype is not due to the absence of MFE2.
mfe2-KO cells contain higher amounts of
-oxidation enzymes than do wild-type cells. We also show that increasing the level
of the
-oxidation enzyme thiolase results in enlarged peroxisomes.
Our results implicate peroxisomal
-oxidation in the control of
peroxisome size and number in yeast.
 |
INTRODUCTION |
Cellular fatty acid degradation into acetyl-CoA units occurs by
-oxidation, a cyclic reaction that shortens fatty acids by two
carbon atoms per round. In higher eukaryotes,
-oxidation systems are
found in both mitochondria and peroxisomes (reviewed in Ref. 1),
whereas in lower eukaryotes such as yeast, this process occurs
exclusively in peroxisomes (reviewed in Ref. 2). The enzymes that
contribute to
-oxidation in yeast include, in order, acyl-CoA
oxidase, multifunctional enzyme type 2 (MFE2)1 (with 2-enoyl-CoA
hydratase and 3-hydroxyacyl-CoA dehydrogenase activities) (3, 4), and
the cleavage enzyme, 3-ketoacyl-CoA thiolase.
Peroxins are proteins that function in peroxisome assembly. Enzymes
involved in peroxisomal
-oxidation are synthesized on free polysomes
and then imported into the matrix of the peroxisome in an
evolutionarily conserved manner that is dependent on a subset of
peroxins and on cis-acting peroxisomal targeting signals
(PTSs) (reviewed in Refs. 5 and 6). Proteins containing a PTS1 (a
carboxyl-terminal tripeptide of the sequence SKL or a conserved variant
thereof) require several peroxins for their import, including Pex5p,
which binds directly to PTS1s. Proteins containing a PTS2, which has
the consensus sequence (R/K)(L/V/I)X5(Q/H)(L/A)
and is found at or near the amino termini of a small subset of
peroxisomal matrix proteins, also require several peroxins for their
import, including Pex7p, which binds directly to PTS2s. An interesting feature of peroxisomes is their ability to import oligomeric proteins (7, 8). 3-ketoacyl-CoA thiolase, the enzyme catalyzing the last step of
peroxisomal
-oxidation, has been shown to be imported as a homodimer
(7, 9).
In many cell types, peroxisomes increase in size and number in response
to certain extracellular stimuli (reviewed in Ref. 10). Evidence
suggests that this regulation is controlled by a subset of peroxins. In
yeast, Pex10p (11), Pex11p (12-15), and Pex16p (16) have each been
shown to play a role in regulating the size and/or number of
peroxisomes in response to growth on carbon sources metabolized by
peroxisomes. In mammalian cells, PEX11
has been shown to induce
peroxisome proliferation in the absence of an external stimulus
(e.g. a hypolipidemic drug such as clofibrate) (17). Other
evidence suggests that there is also metabolic control of peroxisome
abundance and size in mammalian cells. Cells of a patient with a
specific deficiency in acyl-CoA oxidase were shown to have enlarged
peroxisomes that are heterogeneous in size (18). It has also been
reported that human cells lacking either acyl-CoA oxidase or MFE2 have
a 5-fold reduction in peroxisome abundance and a 2-4-fold increase in
peroxisome diameter, as compared with normal cells (19).
Here, we report the identification and characterization of the
MFE2 gene of the yeast Yarrowia lipolytica and
the study of the targeting of its encoded protein, MFE2, to
peroxisomes. We also provide evidence of a role for
-oxidation
enzymes in the regulation of peroxisome size and number in Y. lipolytica, the first evidence for this type of metabolic control
in yeast.
 |
EXPERIMENTAL PROCEDURES |
Yeast Strains and Culture Conditions--
The yeast strains used
in this study are listed in Table I.
Media components were as follows: YEPD, 1% yeast extract, 2% peptone,
2% glucose; YEPA, 1% yeast extract, 2% peptone, 2% sodium acetate;
YPBO, 0.3% yeast extract, 0.5% peptone, 0.5%
K2HPO4, 0.5% KH2PO4,
1% Brij 35, 1% (w/v) oleic acid; YND, 1.34% yeast nitrogen base
without amino acids, 2% glucose; YNO, 1.34% yeast nitrogen base
without amino acids, 0.05% (w/v) Tween 40, 0.2% (w/v) oleic acid;
YNA, 1.34% yeast nitrogen base without amino acids, 2% sodium
acetate. Liquid YNO and YND media and YNO agar plates were supplemented
with 2× Complete Supplement Mixture (minus the appropriate amino acids
or nucleotides) (Bio 101, Vista, CA). YNA agar plates were supplemented
with leucine, uracil, and lysine, each at 50 µg/ml, as required.
Growth was at 30 °C.
Isolation and Sequencing of the MFE2 Gene--
A fragment of the
MFE2 gene was isolated serendipitously from the DNA of a
Y. lipolytica strain containing a PEX16
disruption construct (16) spuriously integrated into its genome. This
strain was unable to use oleic acid as a carbon source. A fragment
containing the disruption construct and flanking genomic DNA was
recovered from this strain and ligated into pGEM7Zf(+) (Promega) to
generate the plasmid p6AD. By sequencing, a 1146-bp fragment of the
MFE2 gene (nucleotides 1090-2235, where +1 is the "A"
nucleotide of the initiation codon) was identified within the
disruption construct. To clone the entire MFE2 gene,
Y. lipolytica genomic DNA was isolated from the wild-type
strain E122, digested with EcoRI, and
fractionated by size. By polymerase chain reaction (PCR) amplification
of DNA fragments within each fraction using oligonucleotides 731 and 742 (Table II), it was determined that
fragments of DNA containing the MFE2 gene were between 6 and
8 kilobase pairs in size. EcoRI-digested genomic DNA of this
size range was ligated into pGEM7Zf(+) to construct a library for
colony hybridization. A fragment of the MFE2 gene amplified
by PCR from p6AD using oligonucleotides 731 and 742 was radiolabeled
with [
-32P]dATP and used to probe this library. One
plasmid, pG7MFE2, was isolated from a positive colony, and both strands
of the ~6.8-kilobase pairs insert were sequenced. The sequence of the
MFE2 protein was deduced from the gene nucleotide sequence and compared
with protein data bases using the BLAST algorithm provided by the
network service of the National Center for Biotechnology Information
(Bethesda, MD).
View this table:
[in this window]
[in a new window]
|
Table II
Oligonucleotides used in this study
Restriction endonuclease recognition sites are underlined. Mutations
introduced by site-directed mutagenesis are indicated in boldface.
|
|
To make an MFE2 expression plasmid, pG7MFE2 was digested
with SphI, and the fragment containing the open reading
frame (ORF) of the MFE2 gene, as well as 1066 and 426 bp of
sequence upstream and downstream of the ORF, respectively, was ligated
into the Escherichia coli/Y. lipolytica shuttle vector
pINA445 (20) cut with SphI to make the plasmid pMFE2
encoding MFE2. pINA445 contains the Y. lipolytica LEU2 gene
for the positive selection of yeast transformants and the Y. lipolytica ARS68 gene for autonomous plasmid replication in
Y. lipolytica cells.
Integrative Disruption of the MFE2 and PEX5 Genes--
The
flanking regions of the MFE2 ORF were amplified from pG7MFE2
using oligonucleotides 909 and 921 for the 5' region and oligonucleotides 922 and UP for the 3' region (Table II). The two
products were used as templates for a second round of PCR using
oligonucleotides 909 and UP. As oligonucleotides 922 and 921 have
SalI recognition sequences and complementary 5' ends, the
second round of PCR generated a single fragment containing both
MFE2 flanking regions separated by a SalI site.
This PCR product was cut with SphI, and the 1467-bp fragment
was ligated into the SphI site of pGEM-7Zf(+). The Y. lipolytica URA3 gene flanked by SalI sites was then
ligated into the unique SalI site to generate the plasmid
p
MFE2. The URA3 gene flanked by 1019 and 426 bp of
MFE2 upstream and downstream regions, respectively, was
excised from p
MFE2 with SphI, and the linear fragment was introduced into the wild-type strain E122 by
electroporation. Strains that converted to uracil prototrophy and that
were unable to grow on oleic acid medium (YNO agar) were further
characterized by Southern blotting. One strain, mfe2-KO, was
confirmed to have the MFE2 ORF replaced by URA3.
The PEX5 disruption strain, pex5-KO2, was made as
described previously (21), except that the URA3 gene was
used in place of the LEU2 gene.
Epitope-tagging of the MFE2 Protein--
A modified
MFE2 gene coding for a MFE2 protein tagged at its amino
terminus was made by inserting a DNA fragment encoding three copies of
the human c-Myc epitope (a gift of David Stewart, Department of
Biochemistry, University of Alberta) in-frame at the 5' end of the
MFE2 ORF. First, a SnaBI site was generated after
the initiation codon of the MFE2 gene using two-step PCR. Essentially, the regions of the MFE2 gene flanking the
proposed SnaBI site were amplified from pG7MFE2 using
oligonucleotides 909 and 945 for the 5' region and oligonucleotides 944 and UP for the 3' region (Table II). The two products were used as
templates for a second round of PCR with oligonucleotides 909 and UP.
As oligonucleotides 944 and 945 have SnaBI recognition
sequences and complementary 5' ends, the second round of PCR generated
a single fragment containing both flanking regions of the
MFE2 gene with a SnaBI site between them. This
product was digested with NcoI and EcoRV, and the
fragment containing the PCR-generated SnaBI site was ligated
into the corresponding sites of pG7MFE2. A fragment with
HindII/XhoI termini encoding the peptide
GEQKLISEEDLNGEQKLISEEDLNGEQKLISEEDLNG, which contains three repeats of the c-Myc epitope (underlined residues) (22), was made blunt with the Klenow fragment of DNA polymerase I and ligated in-frame into the SnaBI site to
generate the plasmid pG7Myc-MFE2. This plasmid was digested with
SphI, and the fragment containing the modified
MFE2 gene, as well as 1066 and 426 bp of sequence upstream
and downstream of the MFE2 gene, respectively, was ligated
into SphI-digested pINA445 to create the plasmid pMyc-MFE2
encoding Myc-MFE2. The region of pMyc-MFE2 that was amplified by PCR
(between the NcoI and EcoRV sites) was determined
to be correct by sequencing.
Construction of a Myc-MFE2
AKL Expression Vector--
A
two-step PCR procedure was used to generate a modified MFE2
gene encoding Myc-MFE2 lacking its carboxyl-terminal tripeptide (Myc-MFE2
AKL). That portion of the MFE2 gene 5' to the
nucleotides encoding the carboxyl-terminal tripeptide of MFE2 was
amplified from pG7Myc-MFE2 with oligonucleotides 909 and 953 (Table
II). The stop codon and downstream sequence of MFE2 were
amplified with oligonucleotides 958 and UP (Table II). The two products were used as templates for a second round of PCR with oligonucleotides 909 and UP. As oligonucleotides 953 and 958 have complementary 5' ends,
the second round of PCR generated a single fragment containing a
modified MFE2 gene encoding Myc-MFE2
AKL. This PCR product
was digested with SphI, and the fragment containing the
modified MFE2 ORF, as well as 1066 and 426 bp of sequence
upstream and downstream, respectively, of the MFE2 gene, was
ligated into the SphI site of pINA445. The MFE2
gene sequence upstream of the ClaI site was exchanged with
the corresponding region of pMyc-MFE2 to generate pMyc-MFE2
AKL. The
remainder of the MFE2 gene was checked to be correct by sequencing.
Immunofluorescence Microscopy--
Cells from YNO-grown cultures
were fixed in 3.7% formaldehyde for 2 or 30 min as indicated and
processed for immunofluorescence microscopy as described (23), except
that spheroplast preparation was done in 100 mM potassium
phosphate (pH 7.5), 1.2 M sorbitol, 40 µg of
Zymolyase-100T (ICN, Aurora, OH)/ml, 28 mM
2-mercaptoethanol for 30 min at 30 °C with gentle agitation. Images
were captured using a Spot Cam digital fluorescence camera (Spot
Diagnostic Instruments, Sterling Heights, MI).
Electron Microscopy--
Whole cells were fixed in 1.5%
KMnO4 for 20 min at room temperature, dehydrated by
successive incubations in increasing concentrations of ethanol, and
embedded in TAAB 812 resin (Marivac, Halifax, Nova Scotia, Canada).
Ultrathin sections were cut using an Ultra-Cut E Microtome
(Reichert-Jung) and examined in a Phillips 410 electron microscope.
Morphometric Analysis of Peroxisomes--
Electron micrographs
were enlarged to a × 16,620 magnification on photographic paper.
Images of cells were cut out and weighed, and the total cell area was
calculated using standards (weights of pieces of photographic paper of
known area). To quantify peroxisome size, the average peroxisome area
was calculated. Essentially, peroxisome profiles were cut out and
weighed, and the total peroxisome area was calculated and divided by
the total number of peroxisomes counted. To quantify peroxisome number,
the numerical density of peroxisomes (number of peroxisomes per
µm3 of cell volume) was calculated by the method of
Weibel and Bolender (24) for spherical organelles as follows. First,
the total number of peroxisome profiles was counted and reported as the
number of peroxisomes per cell area assayed
(NA). Next, the peroxisome volume density
(VV) was calculated for each strain (total
peroxisome area/total cell area assayed). Using the values
VV and NA, the numerical
density of peroxisomes was determined (24).
Site-directed Mutagenesis of the MFE2 Gene--
A two-step PCR
procedure was used to generate a modified MFE2 gene encoding
Myc-MFE2
A
B, a Myc-tagged version of MFE2 containing the mutations
G16S and G324S. A portion of the MFE2 gene 5' to the
nucleotides encoding Gly-16 was amplified from pG7Myc-MFE2 with
oligonucleotides 1016 and 913 (Table II). A portion of the MFE2 gene 3'
to the nucleotides encoding Gly-16 was amplified with oligonucleotides
1015 and 901 (Table II). The two products were used as templates for a
second round of PCR with oligonucleotides 901 and 913. As
oligonucleotides 1015 and 1016 contain the G46A mutation and have
complementary 5' ends, the second round of PCR generated a single
fragment containing a modified MFE2 gene encoding Myc-MFE2
containing the G16S mutation. A DNA fragment encoding MFE2 with the
G324S mutation was made the same way except that oligonucleotides 1013 and 1014 (containing the G1045A and the A1047T mutations) (Table II)
were used in place of oligonucleotides 1015 and 1016. The PCR product
containing G46A was digested with EcoRV and NcoI
and ligated into the corresponding sites of pG7Myc-MFE2 to yield the
plasmid pG7Myc-MFE2
A. Next, the PCR product containing the G1045A
and A1047T mutations was digested with EcoRV and
AflII and ligated into the corresponding sites of
pG7Myc-MFE2
A to yield pG7Myc-MFE2
A
B. pG7Myc-MFE2
A
B was
digested with SphI, and the fragment containing the modified
MFE2 ORF, as well as 1066 and 426 bp of sequence upstream
and downstream of the MFE2 gene, respectively, was ligated
into the SphI site of pINA445 to generate
pMyc-MFE2
A
B.
Overexpression of the POT1 Gene Encoding Peroxisomal
Thiolase--
An overexpression cassette containing the promoter and
terminator regions of the ACT1 gene encoding Y. lipolytica actin was constructed using a two-step PCR procedure.
645 bp upstream of the ACT1 ORF was amplified from Y. lipolytica genomic DNA with oligonucleotides 1009 and 1012 (Table
II). 462 bp downstream of the ACT1 ORF was amplified with
oligonucleotides 1010 and 1011 (Table II). The two products were used
as templates for a second round of PCR with oligonucleotides 1009 and
1010. As oligonucleotides 1011 and 1012 have complementary 5' ends and
contain SnaBI consensus sequences, the second round of PCR
generated a single fragment containing the upstream and downstream
regions of the ACT1 gene separated by a SnaBI
site. This PCR product was digested with BamHI, and the
cassette was ligated into the BamHI site of pINA445 to make
the plasmid pACT-OC. The POT1 gene was amplified from Y. lipolytica genomic DNA using oligonucleotides 564 and 565 (Table II), made blunt with the Klenow fragment of DNA polymerase I, and ligated into the SnaBI site of pACT-OC in the correct
orientation to make the plasmid pTHI-OV.
To quantify thiolase levels, E122 cells transformed with
either pTHI-OV or pINA445 were grown in YND medium overnight. Cells were harvested, and lysates were prepared. Equal amounts of protein from each strain at various dilutions were separated by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to
nitrocellulose, and probed with either anti-thiolase or anti-Kar2p
antibodies. The relative difference in the levels of thiolase in the
pTHI-OV transformed strain versus the wild-type strain was
determined by a comparison of the immunosignals for thiolase from
different dilutions of lysate of each strain.
Antibodies--
Guinea pig antibodies to Y. lipolytica thiolase and rabbit antibodies to Y. lipolytica isocitrate lyase have been described (25). The mouse
monoclonal antibody 9E10 recognizing a 10-amino acid epitope of the
human c-Myc protein was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Rabbit antibodies to Y. lipolytica Kar2p have
been described (26). Rabbit antibodies to Y. lipolytica acyl-CoA oxidase 5 were a kind gift of Jean-Marc Nicaud (Laboratoire de
Génétique des Microorganismes, Thiverval-Grignon, France) and have been described (27). Rabbit antibodies to Saccharomyces cerevisiae malate synthase were a kind gift of Andreas Hartig (Institute of Biochemistry and Molecular Cell Biology, Vienna, Austria). Guinea pig antibodies to Y. lipolytica Pex16p have
been described previously (16). Guinea pig antibodies to Y. lipolytica Pex19p were a kind gift of Gareth Lambkin (Department
of Cell Biology, University of Alberta).
Miscellaneous--
Oligonucleotides were synthesized on an Oligo
1000M DNA synthesizer (Beckman). Sequencing was performed with an ABI
Prism 310 genetic analyzer (Applied Biosystems). DNA was amplified
using Ready To Go PCR beads (Amersham Pharmacia Biotech). Protein
alignments were done using the Clustal W algorithm of Omiga 1.1.3 (Oxford Molecular, Campbell, CA). Preparation of yeast lysates by
disruption with glass beads, growth of E. coli, and
manipulation of DNA and RNA were performed as described (28). Protein
concentrations were determined using a commercially available kit
(Bio-Rad). SDS-PAGE was performed essentially as described (29).
Proteins were transferred to nitrocellulose for immunoblotting using a wet transfer system (30), and antigen-antibody complexes were detected
by enhanced chemiluminescence (Amersham Pharmacia Biotech).
 |
RESULTS |
Isolation and Characterization of the Y. lipolytica MFE2
Gene--
Sequencing of a DNA fragment recovered from a Y. lipolytica strain that contained an incorrectly integrated
PEX16 disruption construct and that failed to grow on oleic
acid-containing medium led to the identification of a 1146-bp piece of
the MFE2 gene encoding peroxisomal
-oxidation MFE2 of
Y. lipolytica. This DNA sequence was used to generate a
probe to isolate the entire Y. lipolytica MFE2 gene by
colony hybridization. Three positively hybridizing colonies were
identified out of 5000 colonies screened, and the plasmids recovered
from each positive colony were shown to be identical by restriction
mapping. Sequencing demonstrated that the insert contained the entire
MFE2 ORF, as well as 3474 and 426 bp upstream and
downstream, respectively, of the ORF.
The Y. lipolytica MFE2 gene and its encoded protein, MFE2,
are shown in Fig. 1. A putative TATA box,
TATATAA, is found between nucleotides -124 and -118 (where +1 is the
"A" nucleotide of the putative initiation codon of the
MFE2 gene). "A" nucleotides are found at positions -1
and -3 upstream of the initiator ATG, a feature common to strongly
expressed genes of Y. lipolytica (31). The upstream
regulatory region of the MFE2 gene contains the sequence CGGTTATAA between nucleotides -459 and -467. This sequence closely resembles the consensus oleic acid-response element
(C/T)GGTT(A/G)TT(C/A/G) of Candida tropicalis
(32) and fits the consensus oleic acid-response element CGGNNNTNA of
S. cerevisiae (33, 34), which are sequences often found
upstream of genes encoding peroxisomal matrix proteins. The
MFE2 gene contains an intron. Y. lipolytica
intron donor and branch sites (31) were identified between nucleotides
172 and 178 and between nucleotides 234 and 245, respectively. The
donor site GTGAGTA fits the consensus donor site GTGAGTPu, whereas the sequence AACTAACACCAG resembles very closely the consensus branch site
(T/C)(A/G)CTAAC(N1-2)CAG. The S. cerevisiae
transcription termination consensus sequence TAG ...
TA(T)GT ... TTT located upstream of poly(A) addition sites (35) is
also a feature of Y. lipolytica genes (31) and is found in
the 3' untranslated region of the MFE2 gene. A eukaryotic
poly(A) addition signal, AATAAA (36), is found between nucleotides 3113 and 3118.

View larger version (104K):
[in this window]
[in a new window]
|
Fig. 1.
Characteristics of the Y. lipolytica
MFE2 gene and its encoded protein, MFE2. A putative
TATA box is boldface and underlined. Putative
transcription termination signals are boxed. A consensus
polyadenylation signal is doubly underlined. Consensus
intron donor and branch sites are boldface and
boxed. A putative oleic acid-response element is
underlined. A consensus PTS1 sequence in the MFE2 protein is
boxed and boldface. These sequence data are
available from EMBL/GenBank/DDBJ under accession number AF198225.
|
|
The protein deduced from the MFE2 nucleotide sequence is 901 amino acid residues in length and has a predicted molecular mass of
97,300 Da. A search of protein data bases using the BLAST algorithm available through the network service of the National Center for Biotechnology Information showed that the encoded protein has a high
degree of homology with peroxisomal MFE2 enzymes of other fungi (Fig.
2). The highest homology is with
Neurospora crassa MFE2, which shares 62% identical residues
and 10% similar residues with Y. lipolytica MFE2. The
carboxyl-terminal tripeptide Ala-Lys-Leu of Y. lipolytica
MFE2 fits the PTS1 consensus sequence.

View larger version (153K):
[in this window]
[in a new window]
|
Fig. 2.
Amino acid sequence alignment of MFE2
proteins of selected fungi. Sequence alignments were generated by
CLUSTAL W. Identical residues (black) or similar residues
(gray) in three or more sequences are shaded.
Similarity rule: A = S = T; D = E; N = Q; R = K; I = L = M = V; F = Y = W. The amino acid
sequences of N. crassa, C. tropicalis, and
S. cerevisiae MFE2 proteins have been deposited in GenBankTM
with accession numbers X80052, X57854, and M86456, respectively.
|
|
The entire MFE2 ORF was deleted by integration of the
Y. lipolytica URA3 gene into the E122 wild-type
strain to create the strain mfe2-KO. The mfe2-KO
strain grew well on media containing acetate (see Fig. 8C)
or glucose (data not shown), which do not require peroxisomal
-oxidation for their metabolism, but failed to grow on medium
containing oleic acid as the carbon source, which does require
peroxisomal
-oxidation for its metabolism (Fig.
3). Transformation of the
mfe2-KO strain with the MFE2 expression plasmid,
pMFE2, led to the restoration of growth on oleic acid medium (Fig.
3).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
Growth of Y. lipolytica
strains on oleic acid-containing medium. The wild-type
strain E122 and the deletion strain mfe2-KO,
transformed with the plasmids indicated, were grown in YND medium
overnight. Cells were harvested by centrifugation, washed, resuspended
in water, spotted onto YNO agar plates and grown for 2 days.
|
|
Synthesis of MFE2 Is Induced by Growth of Y. lipolytica in Oleic
Acid Medium--
Because a putative oleic acid-response element is
present upstream of the MFE2 gene, we determined what
effects growth of Y. lipolytica in oleic acid medium had on
the synthesis of MFE2. To monitor the presence of MFE2, the
MFE2 gene was modified to encode Myc-MFE2, a version of the
protein tagged at its amino terminus with the human c-Myc epitope.
Cells of the mfe2-KO strain transformed with a plasmid
encoding Myc-MFE2 were able to grow on oleic-acid medium (Fig. 3),
indicating that Myc-MFE2 functions as does the wild-type MFE2 protein.
Anti-c-Myc antibodies detected a protein in extracts of wild-type cells
transformed with the plasmid pMyc-MFE2 encoding Myc-MFE2 but not in
extracts of wild-type cells transformed with the parental plasmid
pINA445 (Fig. 4). Myc-MFE2 was much
more abundant in an extract of oleic acid-grown cells than in an
extract of glucose-grown cells, whereas the levels of an endoplasmic
reticulum protein, Kar2p, were unaffected by the composition of the
growth medium (Fig. 4).

View larger version (92K):
[in this window]
[in a new window]
|
Fig. 4.
Synthesis of Myc-MFE2 is increased by growth
of Y. lipolytica in oleic acid-containing medium.
Cells of the wild-type strain E122 transformed with either
pMycMFE2 encoding Myc-MFE2 or the parental plasmid pINA445 were grown
overnight in YND medium, harvested by centrifugation, transferred to
fresh YND or YNO medium, and grown for an additional 9 h. Cells
were harvested, and lysates were prepared by disruption with glass
beads. Equal amounts of protein from each strain under each growth
condition were separated by SDS-PAGE, transferred to nitrocellulose,
and probed with either anti-c-Myc antibodies (top panel) or
anti-Kar2p antibodies (bottom panel). The numbers at the
left indicate the migrations of molecular mass standards (in
kDa).
|
|
Myc-Tagged MFE2 Is Peroxisomal in Wild-type Cells but Is Cytosolic
in a PEX5 Gene Disruption Strain--
Double-labeling, indirect
immunofluorescence microscopy was performed on oleic acid-grown strains
transformed with pMyc-MFE2 to determine the subcellular localization of
MFE2. Myc-MFE2 had a punctate localization that was identical to that
of the peroxisomal matrix enzyme thiolase in both wild-type cells and
mfe2-KO cells (Fig.
5A), indicating that Myc-MFE2
is peroxisomal. Because MFE2 shows a typical PTS1 motif, Ala-Lys-Leu,
at its carboxyl terminus, we examined the localization of Myc-MFE2 in
the strain pex5-KO2, which does not synthesize the PTS1
receptor. Myc-MFE2 gave a diffuse pattern of fluorescence
characteristic of a cytosolic localization in the pex5-KO2
strain, whereas thiolase, which is targeted by a PTS2-mediated pathway,
still showed a punctate pattern of fluorescence characteristic of
peroxisomes (Fig. 5B). Therefore, Myc-MFE2 requires the PTS1
receptor for its targeting to peroxisomes.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 5.
Localization of Myc-MFE2 and
Myc-MFE2 AKL in various strains.
A, strains E122 (top panels) and
mfe2-KO (bottom panels) were transformed with
pMyc-MFE2, grown overnight in YND medium, and then grown for 10 h
in YNO medium. Cells were fixed for 30 min and processed for
double-labeling immunofluorescence microscopy using guinea pig
anti-thiolase (left panels) and mouse anti-c-Myc
(right panels) antibodies. Guinea pig primary antibodies
were detected with fluorescein-conjugated donkey anti-guinea pig IgG
secondary antibodies, and mouse primary antibodies were detected with
rhodamine-conjugated donkey anti-mouse IgG secondary antibodies.
B, strains E122, pex5-KO2, and
mfe2-KO were transformed with either pMyc-MFE2 AKL or
pMyc-MFE2, as indicated. Cells were grown and processed for
immunofluorescence microscopy as described for A except that
cells were fixed for 2 min. Bar, 10 µm.
|
|
The Carboxyl-terminal Tripeptide Ala-Lys-Leu Is Necessary for
Targeting Myc-MFE2 to Peroxisomes but Not in the Presence of
Full-length MFE2--
The data presented above are consistent with the
carboxyl-terminal tripeptide Ala-Lys-Leu of MFE2 acting as a PTS1. To
test whether this tripeptide is a PTS1, a mutant MFE2 gene
encoding a carboxyl-terminally truncated, Myc-tagged version of MFE2,
Myc-MFE2
AKL, was transformed into both the mfe2-KO and
wild-type strains. The mutant MFE2 gene was unable to rescue
growth of mfe2-KO cells on oleic acid-containing medium
(Fig. 3). To determine the localization of Myc-MFE2
AKL in both
strains, double-labeling immunofluorescence microscopy was performed.
In mfe2-KO cells, the truncated protein had a cytosolic
localization, whereas thiolase had a punctate localization
characteristic of peroxisomes (Fig. 5B). These data indicate
that the carboxyl-terminal Ala-Lys-Leu of MFE2 is a PTS1, as it is
essential for the targeting of Myc-MFE2 to peroxisomes.
Next we determined the localization of MFE2
AKL in wild-type cells.
Interestingly, although Myc-MFE2
AKL showed a cytosolic localization
in mfe2-KO cells, it showed a punctate pattern of distribution in wild-type cells that was identical to the distribution of peroxisomal thiolase (Fig. 5B). These results are
consistent with the import of MFE2 as an oligomer into peroxisomes. In
a manner similar to what has been shown for the import of the thiolase dimer in S. cerevisiae (7), the carboxyl-terminally
truncated form of Myc-MFE2 lacking its PTS1 may heterodimerize with
full-length MFE2 encoded in the nucleus and then be targeted to the
peroxisome by virtue of the PTS1 of the full-length MFE2. Although it
is unknown whether Y. lipolytica MFE2 forms an
oligomer, it is important to note that MFE2 of S. cerevisiae
has been shown to form homodimers (3).
Peroxisomes of Oleic Acid-induced mfe2-KO Cells Are Larger and More
Numerous Than Those of the Wild-Type Strain--
Previous evidence has
suggested that human MFE2 has a role in controlling peroxisome
abundance and size (19). We therefore investigated the effects of
disrupting the Y. lipolytica MFE2 gene on peroxisome
morphology. Electron microscopy showed that the peroxisomes of
mfe2-KO cells appeared more variable in size and more
abundant than peroxisomes of wild-type cells (Fig.
6A). Also, the peroxisomes of
the mutant strain were often clustered, whereas the peroxisomes of the
wild-type strain were usually well separated (Fig. 6A).
Morphometric analysis (24) showed that mfe2-KO cells had a
numerical density of peroxisomes that was approximately 2.5 times that
of wild-type cells (Table III, rows 1 and 2). Peroxisomes of the mfe2-KO strain
were also much more variable in size than those of wild-type cells,
with mutant cells having many peroxisomes greater than 0.4 µm2 in area and wild-type cells having essentially no
peroxisomes greater than 0.4 µm2 in area (Fig.
6B). In addition, the average area of mfe2-KO
peroxisomes was significantly larger than the average area of
E122 peroxisomes (Table III, rows 1 and 2). Using the
Student two-sample t test for unequal variance, the average
peroxisome area of mfe2-KO cells was found to be 1.26 ± 0.07 times larger than that of wild-type cells, with a 95%
confidence interval.

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 6.
Peroxisomes are larger, more abundant and
more variable in size in mfe2-KO cells than in
wild-type cells. A, ultrastructure of mutant
mfe2-KO and wild-type E122 cells. Cells were
grown in YEPD medium overnight, transferred to YPBO medium, and grown
in YPBO medium for 14 h. Cells were fixed and processed for
electron microscopy. P, peroxisome; M,
mitochondrion; N, nucleus; V, vacuole.
Bar, 1 µm. B, morphometric analysis of oleic
acid-grown E122 (left panel) and
mfe2-KO (right panel) cells. Electron micrographs
encompassing 825 µm2 of wild-type cell area and 553 µm2 of mfe2-KO cell area were enlarged to a
magnification of × 16,620 on photographic paper. Peroxisome
profiles were cut out and weighed, and the total peroxisome area for
each strain was calculated. Next, the areas of individual peroxisomes
were calculated, and peroxisomes were separated into size categories. A
histogram was generated for each strain depicting the percentage of
total peroxisome area occupied by the peroxisomes of each category. The
numbers along the x axis are the maximum sizes of
peroxisomes in each category (in µm2).
|
|
The fact that peroxisomes are more abundant in the mfe2-KO
strain than in the wild-type strain was not obvious from
immunofluorescence microscopy (Fig. 5B). This apparent
difference between electron microscopic and immunofluorescence
microscopic analyses can be explained by the fact that peroxisomes of
the deletion strain are often clustered (Fig. 6A), and a
cluster of peroxisomes can appear as one large peroxisome in
immunofluorescence microscopy (37).
mfe2-KO Cells Have Enlarged Peroxisomes When Grown on a Carbon
Source Not Metabolized by Peroxisomal
-Oxidation--
Our
morphological analysis of oleic acid-induced mfe2-KO cells
suggested a dysregulation of peroxisome size and number in the absence
of MFE2. To better understand the mechanism responsible for this
observation, we investigated the morphology of mfe2-KO cells
grown in medium containing acetate, a carbon source not requiring
-oxidation for its metabolism. Peroxisomes of mfe2-KO cells grown in acetate were considerably larger than those of wild-type
cells in electron micrographs (Fig. 7).
Morphometric analysis of acetate-grown strains showed that the average
area of peroxisomes of mfe2-KO cells was 3.2 times that of
wild-type cells, whereas the number of peroxisomes counted per
µm2 of cell area was similar for both strains (Table III,
rows 3 and 4). However, a similar peroxisome count does not necessarily
mean that the average number of peroxisomes per cell is the same for both strains, because the larger a peroxisome is, the greater the
probability of observing it in any given micrograph (24). To estimate
the peroxisome number for cells of each strain, we calculated the
peroxisome numerical density, a value that takes into account
peroxisome size (24). This calculation showed that in contrast to what
was observed for cells grown in oleic acid, mfe2-KO cells
contained approximately half as many peroxisomes as did wild-type cells
following growth in acetate (Table III, rows 3 and
4).

View larger version (133K):
[in this window]
[in a new window]
|
Fig. 7.
Peroxisomes of mfe2-KO cells
are larger than those of wild-type cells when grown in
acetate-containing medium. Ultrastructure of mfe2-KO
and E122 cells grown in acetate-containing YEPA medium for
24 h. Cells were fixed and processed for electron microscopy.
P, peroxisome; M, mitochondrion; N,
nucleus; V, vacuole. Bar, 1 µm.
|
|
Enlarged Peroxisomes Are Not Caused by the Absence of MFE2
Protein--
To determine whether the enlarged peroxisomes present in
mfe2-KO cells were caused by the absence of MFE2 protein or
the lack of a functional
-oxidation pathway, we determined whether a
nonfunctional version of Myc-MFE2 could reverse the morphological
defects of the mfe2-KO strain. S. cerevisiae MFE2
has two (3R)-hydroxyacyl-CoA dehydrogenase domains
(DA and DB in Fig.
8A) that are required for the
-oxidation of fatty acids (4). A form of MFE2 containing the
mutations G16S and G329S in the nucleotide-binding sites of the two
dehydrogenase domains has been shown to be nonfunctional in peroxisomal
-oxidation (4). We identified two consensus nucleotide-binding sites
in Y. lipolytica MFE2, and alignment of the S. cerevisiae and Y. lipolytica nucleotide-binding sites revealed that Gly-16 and Gly-324 of Y. lipolytica MFE2
correspond to Gly-16 and Gly-329 of S. cerevisiae MFE2,
respectively (Fig. 8B). The plasmid pMyc-MFE2
A
B
expressing Myc-MFE2
A
B, which contains the mutations G16S and
G324S, was constructed and transformed into mfe2-KO cells.
The mfe2-KO strain transformed with pMyc-MFE2
A
B, like
the mfe2-KO strain transformed with the empty plasmid
pINA445, was unable to grow on agar medium containing oleic acid as the carbon source, whereas the mfe2-KO strain transformed with a
plasmid expressing Myc-MFE2 grew well on this medium (Fig.
8C, second panel). All three strains grew well on
agar medium containing acetate as the carbon source (Fig.
8C, top panel). Myc-MFE2
A
B and Myc-MFE were
detected by immunoblot analysis of yeast lysates with anti-c-Myc
antibodies. The levels of Myc-MFE2
A
B and Myc-MFE2 were similar in
the yeast lysates in which they were expressed (Fig. 8C,
third panel). The levels of the endoplasmic reticulum protein Kar2p were similar in the lysates of all three strains, confirming that equal amounts of total protein were analyzed (Fig. 8C, bottom panel). Thus, Myc-MFE2
A
B is
unable to restore fatty acid
-oxidation activity to the
mfe2-KO strain. When grown on acetate-containing medium, the
mfe2-KO strain transformed with pMyc-MFE2
A
B, like the
mfe2-KO strain transformed with the empty plasmid pINA445,
had peroxisomes larger than those of the mfe2-KO strain
transformed with pMyc-MFE2, which encodes a functional version of MFE2
(Fig. 9). The average area of peroxisomes
was determined for each strain (Table III, rows 5-7). Peroxisomes of the mfe2-KO strain synthesizing Myc-MFE2
A
B were larger
than peroxisomes of the wild-type strain, but not as large as
peroxisomes of the disruption strain. Because the mfe2-KO
strain expressing normal levels of a nonfunctional form of Myc-MFE2
still contained enlarged peroxisomes, the presence of enlarged
peroxisomes in the mfe2-KO strain was not the result of the
absence of MFE2 protein.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 8.
Expression of
Myc-MFE2 A B does not
restore growth on oleic acid medium to the mfe2-KO
strain. A, domains of yeast MFE2. The two
(3R)-hydroxyacyl-CoA dehydrogenase domains (DA
and DB) are represented by solid lines. The
2-enoyl-CoA hydratase 2 domain (H) is represented by an
open box. Nucleotide-binding sites in the dehydrogenase
domains are represented by closed boxes. B,
sequence alignment of the nucleotide-binding sites of S. cerevisiae and Y. lipolytica MFE2 proteins. Residues
identical or similar in three or more sequences are indicated in
boldface. Similarity rules: A = S = T; D = E;
N = Q; R = K; I = L = M = V; F = Y = W. Conserved glycine residues mutated in Myc-MFE2 A B are
boxed. Residues are numbered at the right.
C, growth characteristics and protein profiles of the
mfe2-KO strain transformed with pMyc-MFE2 A B,
pMyc-MFE2, or pINA445. Strains were grown as described in the legend to
Fig. 3 and spotted onto YNA agar (top panel) and YNO agar
(second panel from top). Strains were also grown overnight
in YND medium, transferred to YNO medium, and grown for an additional
10 h in YNO medium. Cells were harvested, and lysates were
prepared by disruption with glass beads. Equal amounts of protein from
each strain were separated by SDS-PAGE, transferred to nitrocellulose,
and probed with either anti-c-Myc antibodies (third panel from
top) or anti-Kar2p antibodies (bottom panel).
|
|

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 9.
Expression of
Myc-MFE2 A B does not
reverse the morphological defects of the mfe2-KO
strain. Cells of the mfe2-KO strain transformed
with pMyc-MFE2 A B, pMyc-MFE2, or the parental plasmid pINA445 were
grown overnight in YNA medium and processed for electron microscopy.
P, peroxisome; M, mitochondrion; N,
nucleus. Bar, 1 µm.
|
|
-Oxidation Enzyme Levels Are Increased in the mfe2-KO
Strain--
An analysis of the levels of several peroxisomal proteins
in total cell lysates of the mutant and wild-type strains grown in
glucose-, oleic acid-, or acetate-containing medium showed that two
peroxisomal
-oxidation enzymes, thiolase and acyl-CoA oxidase 5 (one
of five Y. lipolytica acyl-CoA oxidase isoenzymes (27)),
were noticeably increased in mfe2-KO cells as compared with
wild-type cells by growth in each carbon source (Fig.
10). The levels of two peroxisomal
enzymes of the glyoxylate cycle, isocitrate lyase and malate synthase,
appeared unchanged from the levels in wild-type cells or were
marginally increased in mfe2-KO cells. The levels of two
peroxins that associate with the peroxisome membrane, Pex16p and
Pex19p, were not increased in mfe2-KO cells compared with
wild-type cells, and in fact, both peroxins appeared less abundant in
the deletion strain than in the wild-type strain following growth in
oleic acid. The levels of the endoplasmic reticulum protein Kar2p were
similar in lysates of each strain under all growth conditions,
confirming that equal amounts of total protein were analyzed.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 10.
Abundance of various peroxisomal matrix
proteins and peroxins in wild-type and mfe2-KO cells
under different growth conditions. Wild-type E122 and
mutant mfe2-KO cells were grown in acetate-containing YEPA
medium overnight, transferred to oleic acid-containing YPBO,
glucose-containing YEPD, or YEPA medium, and grown for an additional
14 h. Cells were lysed, and equal amounts of protein (25 µg)
from lysates of cells from each growth condition (indicated at the
top) were separated by SDS-PAGE and transferred to
nitrocellulose. The nitrocellulose was probed with antibodies to the
proteins indicated at the right. Immunodetection was by
enhanced chemiluminescence. THI, thiolase; Aox5,
acyl-CoA oxidase isozyme 5; ICL, isocitrate lyase;
MLS, malate synthase.
|
|
Increased Amounts of the
-Oxidation Enzyme Thiolase Result in
Enlarged Peroxisomes--
It had been shown previously that increased
amounts of peroxisomal matrix proteins lead to enlarged peroxisomes in
cells of S. cerevisiae and the yeast Hansenula
polymorpha (38-40). We investigated whether increased amounts of
peroxisomal
-oxidation enzymes might contribute to peroxisome
enlargement in Y. lipolytica cells. We overexpressed
POT1, the gene encoding peroxisomal thiolase, in wild-type
cells and analyzed the effect of this overexpression on peroxisome
size. We looked at peroxisome size after growth of cells in
glucose-containing medium, because the level of endogenous thiolase is
very low under this condition (Fig. 10). Therefore, a high relative
increase in the abundance of thiolase can be readily achieved by
overexpression of its gene in wild-type cells grown in glucose. Also,
because peroxisomes are normally very small in cells grown in glucose
(Fig. 11B, top
panel), small changes in peroxisome size should be readily
apparent.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 11.
Increased levels of the
-oxidation enzyme thiolase lead to enlarged
peroxisomes. Wild-type E122 cells transformed with
either the POT1 overexpression plasmid pTHI-OV or the
parental plasmid pINA445 were grown in glucose-containing YND medium
overnight. A, equal amounts of protein from cell lysates
were separated by SDS-PAGE and transferred to nitrocellulose. The
nitrocellulose was probed with antibodies to the proteins indicated at
the right. B, cells were processed for electron
microscopy. P, peroxisome; M, mitochondrion;
N, nucleus. Bar, 1 µm.
|
|
After growth in glucose, wild-type cells transformed with pTHI-OV
overexpressing POT1 contained approximately 8-fold more thiolase than did wild-type cells transformed with the parental plasmid
pINA445 (Fig. 11A). This increase in the amount of thiolase led to peroxisomes in the pTHI-OV transformed strain (Fig. 11B, top panel) that were noticeably larger than those of the pINA445 transformed strain (Fig. 11B, bottom panel). The
average area and the numerical density of peroxisomes was determined
for each strain (Table III, rows 8 and 9). Peroxisomes of the strain
overexpressing POT1 were almost twice as large as
peroxisomes of the wild-type strain, whereas the numerical density of
peroxisomes was similar for both strains. These results suggest that an
increase in abundance of peroxisomal
-oxidation enzymes in the
mfe2-KO strain contributes to the enlarged peroxisomes seen
in this strain.
 |
DISCUSSION |
The MFE2 gene of Y. lipolytica encodes
peroxisomal MFE2, which shares a high degree of sequence homology with
MFE2 proteins from other fungi. Y. lipolytica cells devoid
of MFE2 are unable to utilize oleic acid as a carbon source, as has
been observed for S. cerevisiae (4). The Y. lipolytica
MFE2 gene contains a putative upstream oleic acid-response
element, as do the genes of S. cerevisiae (33, 34) and
C. tropicalis (32), and consistent with this, the synthesis
of Myc-MFE2, a c-Myc epitope-tagged version of the protein, was induced
by growth of Y. lipolytica on oleic acid-containing medium.
Y. lipolytica MFE2 contains a PTS1, as do the MFE2 proteins
of C. tropicalis and S. cerevisiae, and it is
essential for targeting to peroxisomes. Similar to S. cerevisiae MFE2, which has been shown to form homodimers (3), our
evidence suggests that Y. lipolytica MFE2 is targeted to
peroxisomes as an oligomer.
Y. lipolytica MFE2 appears to have a role in peroxisome
biogenesis. Cells of the deletion strain mfe2-KO grown in
oleic acid contain more and larger peroxisomes than do wild-type cells
grown under the same conditions. Also, peroxisomes of the
mfe2-KO strain are more heterogeneous in size than those of
wild-type cells and are often found in close proximity to one other.
mfe2-KO cells grown in acetate, a carbon source not
requiring peroxisomes for its metabolism, have larger peroxisomes than
do identically grown wild-type cells, but only half as many. These data
suggest that MFE2 contributes to the regulation of peroxisome size and number.
mfe2-KO cells contain enlarged peroxisomes in the presence
of both oleic acid and acetate carbon sources. Consistent with our
observations in yeast, peroxisomes are enlarged in a mammalian cell
line lacking MFE2 (19). The larger size of mfe2-KO
peroxisomes may be the result of increased amounts of other peroxisomal
-oxidation enzymes in this strain. It has been shown previously that
high expression of genes encoding matrix enzymes in cells of H. polymorpha and S. cerevisiae leads to enlarged
peroxisomes (38-40). Here, we show that increasing the amount of
thiolase in Y. lipolytica cells leads to enlarged
peroxisomes, indicating that increased levels of
-oxidation proteins
in mfe2-KO cells may contribute to the enlarged peroxisomes
seen in this strain, although, interestingly, similar levels of
Myc-MFE2
A
B and Myc-MFE2 (Fig. 8C) resulted in smaller
peroxisomes being seen in the mfe2-KO strain expressing pMyc-MFE2
A
B relative to mfe2-KO strain transformed
with the parental plasmid pINA445 alone (see Table III, rows
7 and 6 respectively). Additionally, we have shown that
the increase in peroxisome size seen for mfe2-KO cells is
not due to the absence of MFE2 protein, as a nonfunctional form of MFE2
expressed at normal MFE2 levels is unable to complement this
morphological defect. Therefore, it appears that the inability of MFE2
to function in fatty acid
-oxidation leads to enlarged peroxisomes.
Deletion of the MFE2 gene affects peroxisome number.
Following growth in oleic acid, mfe2-KO cells have more
peroxisomes than do wild-type cells. In contrast, mfe2-KO
cells grown in acetate have fewer peroxisomes than do wild-type cells.
A possible reason for this dichotomy is that the number of peroxisomes
within a cell may be affected by the rate of cell division. It has been proposed that the number of peroxisomes in a cell is the result of both
peroxisome accumulation due to proliferation and peroxisome loss due to
cell division (41). In contrast to wild-type cells, cells of the
mfe2-KO deletion strain cannot readily divide in oleic
acid-containing medium, so few of their peroxisomes segregate to
budding daughter cells. If peroxisomes continue to proliferate in
mfe2-KO cells in the absence of cell division, possibly
because of the inability of the strain to metabolize oleic acid,
peroxisomes will accumulate in mother cells of the mfe2-KO
strain, thereby effectively increasing the number of peroxisomes per
cell. Consistent with this scenario is the fact that in acetate,
mfe2-KO cells divide at the rate of wild-type cells and do
not have more peroxisomes than do wild-type cells. An alternative
possibility for the increased number of peroxisomes in the oleic
acid-grown mfe2-KO cells is that disruption of the
MFE2 gene causes an increased rate of peroxisome proliferation under these conditions. However, how this would occur is
not readily apparent. Nevertheless, deletion of the MFE2 gene does affect the number of peroxisomes in Y. lipolytica,
whether due to a secondary effect of cell division or a primary effect of peroxisome proliferation.
It should be noted that although peroxisomes in the mfe2-KO
strain are 2.5 times more abundant than, or half as abundant as, peroxisomes of the wild-type strain (depending on the growth
condition), Chang et al. (19) observed that peroxisomes are
5-fold less abundant in human cells lacking MFE2 than in normal cells.
One reason for the difference between yeast and human cells may be the
method of analysis in that the human peroxisomes were observed using
only immunofluorescence microscopy. If peroxisomes in the mutant human
cells are clustered as they are in oleic acid-induced mfe2-KO cells, the number of peroxisomes may have been
underestimated by using immunofluorescence microscopy. Alternatively,
this difference in peroxisome number between yeast and human cells may
indicate a difference in the mechanisms regulating peroxisome abundance in these two systems. Future studies will be aimed at further determining the molecular players and events involved in these mechanisms.
 |
ACKNOWLEDGEMENT |
We thank Honey Chan for technical assistance
with electron microscopy.
 |
FOOTNOTES |
*
This work was supported by a grant from the Medical Research
Council of Canada (to R. A. R.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF198225, X80052, X57854, and M86456.
Recipient of a Medical Research Council of Canada Studentship.
§
Recipient of a Studentship from the Alberta Heritage Foundation for
Medical Research.
¶
A Medical Research Council of Canada Senior Scientist and an
International Research Scholar of the Howard Hughes Medical Institute. To whom correspondence should be addressed: Dept. of Cell Biology, 5-14 Medical Sciences Bldg., University of Alberta, Edmonton, Alberta T6G 2H7, Canada. Tel.: 780-492-9868; Fax: 780-492-9278; E-mail: rick.rachubinski@ualberta.ca.
Published, JBC Papers in Press, April 27, 2000, DOI 10.1074/jbc.M909285199
 |
ABBREVIATIONS |
The abbreviations used are:
MFE2, multifunctional enzyme type 2;
ORF, open reading frame;
PCR, polymerase
chain reaction;
PTS, peroxisomal targeting signal;
PAGE, polyacrylamide
gel electrophoresis;
bp, base pair(s).
 |
REFERENCES |
| 1.
|
Hashimoto, T.
(1999)
Neurochem. Res.
24,
551-563
|
| 2.
|
Endrizzi, A.,
Pagot, Y.,
Le Clainche, A.,
Nicaud, J.-M.,
and Belin, J.-M.
(1996)
Crit. Rev. Biotechnol.
16,
301-329
|
| 3.
|
Hiltunen, J. K.,
Wenzel, B.,
Beyer, A.,
Erdmann, R.,
Fosså, A.,
and Kunau, W.-H.
(1992)
J. Biol. Chem.
267,
6646-6653
|
| 4.
|
Qin, Y.-M.,
Marttila, M. S.,
Haapalainen, A. M.,
Siivari, K. M.,
Glumoff, T.,
and Hiltunen, J. K.
(1999)
J. Biol. Chem.
274,
28619-28625
|
| 5.
|
Subramani, S.
(1998)
Physiol. Rev.
78,
171-188
|
| 6.
|
Hettema, E. H.,
Distel, B.,
and Tabak, H. F.
(1999)
Biochim. Biophys. Acta
1451,
17-34
|
| 7.
|
Glover, J. R.,
Andrews, D. W.,
and Rachubinski, R. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10541-10545
|
| 8.
|
McNew, J. A.,
and Goodman, J. M.
(1994)
J. Cell Biol.
127,
1245-1257
|
| 9.
|
Titorenko, V. I.,
Smith, J. J.,
Szilard, R. K.,
and Rachubinski, R. A.
(1998)
J. Cell Biol.
142,
403-420
|
| 10.
|
van den Bosch, H.,
Schutgens, R. B. H.,
Wanders, R. J. A.,
and Tager, J. M.
(1992)
Annu. Rev. Biochem.
61,
157-197
|
| 11.
|
Tan, X.,
Waterham, H. R.,
Veenhuis, M.,
and Cregg, J. M.
(1995)
J. Cell Biol.
128,
307-319
|
| 12.
|
Erdmann, R.,
and Blobel, G.
(1995)
J. Cell Biol.
128,
509-523
|
| 13.
|
Marshall, P. A.,
Krimkevich, Y. I.,
Lark, R. H.,
Dyer, J. M.,
Veenhuis, M.,
and Goodman, J. M.
(1995)
J. Cell Biol.
129,
345-355
|
| 14.
|
Sakai, Y.,
Marshall, P. A.,
Saiganji, A.,
Takabe, K.,
Saiki, H.,
Kato, N.,
and Goodman, J. M.
(1995)
J. Bacteriol.
177,
6773-6781
|
| 15.
|
Marshall, P. A.,
Dyer, J. M.,
Quick, M. E.,
and Goodman, J. M.
(1996)
J. Cell Biol.
135,
123-136
|
| 16.
|
Eitzen, G. A.,
Szilard, R. K.,
and Rachubinski, R. A.
(1997)
J. Cell Biol.
137,
1265-1278
|
| 17.
|
Schrader, M.,
Reuber, B. E.,
Morrell, J. C.,
Jimenez-Sanchez, G.,
Obie, C.,
Stroh, T. A.,
Valle, D.,
Schroer, T. A.,
and Gould, S. J.
(1998)
J. Biol. Chem.
273,
29607-29614
|
| 18.
|
Poll-The, B. T.,
Roels, F.,
Ogier, H.,
Scotto, J.,
Vamecq, J.,
Schutgens, R. B. H.,
Wanders, R. J. A.,
van Roermund, C. W. T.,
van Wijland, M. J. A.,
Schram, A. W.,
Tager, J. M.,
and Saudubray, J.-M.
(1988)
Am. J. Hum. Genet.
42,
422-434
|
| 19.
|
Chang, C.-C.,
South, S.,
Warren, D.,
Jones, J.,
Moser, A. B.,
Moser, H. W.,
and Gould, S. J.
(1999)
J. Cell Sci.
112,
1579-1590
|
| 20.
|
Nuttley, W. M.,
Brade, A. M.,
Gaillardin, C.,
Eitzen, G. A.,
Glover, J. R.,
Aitchison, J. D.,
and Rachubinski, R. A.
(1993)
Yeast
9,
507-517
|
| 21.
|
Szilard, R. K.,
Titorenko, V. I.,
Veenhuis, M.,
and Rachubinski, R. A.
(1995)
J. Cell Biol.
131,
1453-1469
|
| 22.
|
Kolodziej, P. A.,
and Young, R. A.
(1991)
Methods Enzymol.
194,
508-519
|
| 23.
|
Pringle, J. R.,
Adams, A. E. M.,
Drubin, D. G.,
and Haarer, B. K.
(1991)
Methods Enzymol.
194,
565-602
|
| 24.
|
Weibel, E. R.,
and Bolender, P.
(1973)
in
Principles and Techniques of Electron Microscopy
(Hayat, M. A., ed), Vol. 3
, pp. 237-296, Van Nostrand Reinhold, New York
|
| 25.
|
Eitzen, G. A.,
Titorenko, V. I.,
Smith, J. J.,
Veenhuis, M.,
Szilard, R. K.,
and Rachubinski, R. A.
(1996)
J. Biol. Chem.
271,
20300-20306
|
| 26.
|
Titorenko, V. I.,
Ogrydziak, D. M.,
and Rachubinski, R. A.
(1997)
Mol. Cell. Biol.
17,
5210-5226
|
| 27.
|
Wang, H. J.,
Le Dall, M.-T.,
Waché, Y.,
Laroche, C.,
Belin, J.-M.,
Gaillardin, C.,
and Nicaud, J.-M.
(1999)
J. Bacteriol.
181,
5140-5148
|
| 28.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1989)
Current Protocols in Molecular Biology
, Greene Publishing Associates, New York
|
| 29.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 30.
|
Burnette, W. N.
(1981)
Anal. Biochem.
112,
195-203
|
| 31.
|
Barth, G.,
and Gaillardin, C.
(1997)
FEMS Microbiol. Rev.
19,
219-237
|
| 32.
|
Sloots, J. A.,
Aitchison, J. D.,
and Rachubinski, R. A.
(1991)
Gene
105,
129-134
|
| 33.
|
Filipits, M.,
Simon, M. M.,
Rapatz, W.,
Hamilton, B.,
and Ruis, H.
(1993)
Gene
132,
49-55
|
| 34.
|
Karpichev, I. V.,
and Small, G. M.
(1998)
Mol. Cell. Biol.
18,
6560-6570
|
| 35.
|
Zaret, K. S.,
and Sherman, F.
(1982)
Cell
28,
563-573
|
| 36.
|
Proudfoot, N. J.,
and Brownlee, G. G.
(1976)
Nature
263,
211-214
|
| 37.
|
Zhang, J. W.,
Han, Y.,
and Lazarow, P. B.
(1993)
J. Cell Biol.
123,
1133-1147
|
| 38.
|
Distel, B.,
van der Leij, I.,
Veenhuis, M.,
and Tabak, H. F.
(1988)
J. Cell Biol.
107,
1669-1675
|
| 39.
|
Gödecke, A.,
Veenhuis, M.,
Roggenkamp, R.,
Janowicz, Z. A.,
and Hollenberg, C. P.
(1989)
Curr. Genet.
16,
13-20
|
| 40.
|
Roggenkamp, R.,
Didion, T.,
and Kowallik, K. V.
(1989)
Mol. Cell. Biol.
9,
988-994 |